View source for CR:DOI:ee68d2935f07f1456c07b4a6efab4f88

{{#scite:
 |reference=rybak2020th
 |type=article-journal
 |title=Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
 |author=Michael J Rybak;Jennifer Le;Thomas P Lodise;Donald P Levine;John S Bradley;Catherine Liu;Bruce A Mueller;Manjunath P Pai;Annie Wong-Beringer;John C Rotschafer;Keith A Rodvold;Holly D Maples;Benjamin M Lomaestro|+sep=;
 |journal=American Journal of Health-System Pharmacy
 |publisher=Oxford University Press (OUP)
 |year=2020
 |doi=10.1093/ajhp/zxaa036
 |subject=Health Policy;Pharmacology|+sep=;
 |issn=1079-2082;1535-2900|+sep=;
 |retrieved-from=https://dx.doi.org/
 |retrieved-on=2020-04-04
 |@show=true
}}